The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A murine MODEL of e-cigarettes exposure to evaluate the carcinogenic effects of vaping on the bladder urothelium.
 
ibardo zambrano
No Relationships to Disclose
 
Ujjawal Manocha
No Relationships to Disclose
 
Weida Gong
No Relationships to Disclose
 
Yi-Hsuan Tsai
No Relationships to Disclose
 
Manhua Zhu
No Relationships to Disclose
 
Melissa A. Herman
No Relationships to Disclose
 
Marc Bjurlin
No Relationships to Disclose
 
William Y. Kim
Leadership - Advanced Chemotherapy Technologies (I)
Stock and Other Ownership Interests - Abbvie; Amgen; Arvinas; Arvinas; BeiGene; Bristol-Myers Squibb; FibroGen; Fibrogen; G1 Therapeutics; Illumina; Johnson & Johnson; Kura Oncology; NantWorks; Natera; Oramed; Spectrum Pharmaceuticals; Zentalis
Honoraria - H3 Biomedicine; Takeda
Consulting or Advisory Role - Foundation Medicine; GeneCentric
Research Funding - Foundation Medicine; GeneCentric; Merck
Patents, Royalties, Other Intellectual Property - BASE47 bladder cancer subtype classifier; PurIST (Purity Independent Subtyping of Tumors) (I)
Travel, Accommodations, Expenses - H3 Biomedicine; Takeda